Neither Lorazepam Nor Alprazolam is Ideal for Elderly Patients
Both lorazepam and alprazolam should be avoided in elderly patients whenever possible, as the American Geriatrics Society Beers Criteria recommends against the use of all benzodiazepines in older adults independent of diagnosis 1. However, if a benzodiazepine must be used, neither agent has a clear safety advantage over the other in this population.
Why Both Should Be Avoided
The 2019 AGS Beers Criteria explicitly lists benzodiazepines as potentially inappropriate medications for older adults due to:
- Increased sensitivity to benzodiazepines in elderly patients
- Risk of cognitive impairment and delirium
- Increased fall risk and fractures
- Motor vehicle accidents
- Physical dependence and withdrawal complications 1
The most recent 2025 geriatric emergency guidelines reinforce this, noting that benzodiazepines carry substantial adverse event risks in older adults, with higher doses associated with greater frequency of adverse events, primarily respiratory complications 2.
Pharmacokinetic Considerations
Alprazolam (Xanax)
- Reduced clearance in elderly: Geriatric patients have higher plasma concentrations due to 20% decreased clearance compared to younger adults 3
- Requires dosage reduction per FDA labeling 3
- Particular concern for abuse and dependence: Alprazolam has unique pharmacokinetic properties that increase its potential for abuse, dependence, and challenging withdrawal 4
Lorazepam (Ativan)
- Also shows reduced clearance: 20% decrease in total body clearance in elderly (60-84 years) compared to younger subjects 5
- Dose-dependent toxicity: Higher doses associated with significantly greater adverse events, particularly respiratory depression 2
- Documented cognitive impairment: Retrospective studies show lorazepam commonly causes oversedation, amnestic disorders, confusion, depression, ataxia, and drug-induced pseudodementia in elderly patients 6
Clinical Reality: No Winner Here
While older literature from the 1980s-1990s suggested that short-acting benzodiazepines like lorazepam and alprazolam might be preferable to long-acting agents 7, 8, this recommendation has been superseded by current guidelines that recommend avoiding all benzodiazepines in the elderly 1.
The critical point: Both drugs show similar 20% reductions in clearance in elderly patients 5, 3, meaning both accumulate more than in younger adults and both require dosage reduction.
When Benzodiazepines Are Unavoidable
The only scenarios where benzodiazepines may be necessary in elderly patients are:
- Alcohol withdrawal
- Benzodiazepine withdrawal 2
In these specific situations:
- Start with the lowest possible dose
- Use oral formulations when feasible (parenteral routes increase adverse events) 2
- Avoid high doses of either agent
- Plan for short-term use only (2 weeks maximum with re-evaluation) 9
- Implement a gradual taper (2-12 weeks) if used for ≥6 weeks 9, 10
Preferred Alternatives
For anxiety in elderly patients, consider:
- SSRIs as first-line treatment (especially when comorbid depression exists) 11
- Buspirone (non-toxic antianxiety agent, though more data needed) 7
- Cognitive behavioral therapy 11
- Oral quetiapine for severe agitation (favorable safety profile per 2025 guidelines) 2
Common Pitfalls to Avoid
- Don't assume "short-acting is safer": Both lorazepam and alprazolam are short-acting, yet both carry significant risks in elderly patients
- Don't use high doses: Dose-response relationship for toxicity is clear 2
- Don't combine with other CNS depressants: Particularly dangerous with opioids or alcohol 3
- Don't abruptly discontinue: Risk of severe withdrawal including seizures and delirium 3, 10
- Don't ignore cognitive side effects: Memory impairment and pseudodementia can be misdiagnosed as true dementia 6